Published in Mol Biosyst on April 26, 2016
Unraveling the Anticancer Effect of Curcumin and Resveratrol. Nutrients (2016) 0.75
Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69
GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem (2009) 23.19
Unified approach for molecular dynamics and density-functional theory. Phys Rev Lett (1985) 7.13
P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. J Chem Theory Comput (2008) 4.56
Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res (2006) 3.12
Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol (2007) 2.65
Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle (2008) 2.10
Androgen receptor signaling in prostate cancer development and progression. J Carcinog (2011) 1.90
Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci (2002) 1.88
Androgen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem (2006) 1.85
Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position. Eur J Med Chem (2006) 1.65
Resveratrol: one molecule, many targets. IUBMB Life (2008) 1.64
Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem (2004) 1.50
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47
Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem (2002) 1.36
Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis (2010) 1.24
Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol Nutr Food Res (2011) 1.20
Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging (2008) 1.17
Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res (1999) 1.17
Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin (2014) 1.15
HyperChem: a software package for computational chemistry and molecular modeling. Biotechniques (1993) 1.14
Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. J Med Chem (2004) 1.10
Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol (2007) 1.09
Distribution of resveratrol and stilbene synthase in young grape plants (Vitis vinifera L. cv. Cabernet Sauvignon) and the effect of UV-C on its accumulation. Plant Physiol Biochem (2009) 0.97
Molecular basis for gene-specific transactivation by nuclear receptors. Biochim Biophys Acta (2010) 0.97
Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS One (2013) 0.95
Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. J Nutr Sci Vitaminol (Tokyo) (2007) 0.94
Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor. Asian J Androl (2010) 0.90
Repressive effects of resveratrol on androgen receptor transcriptional activity. PLoS One (2009) 0.90
Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells. Anticancer Res (2011) 0.88
Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans. Sci Rep (2013) 0.87
Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. Prostate (2013) 0.87
Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer. Int J Mol Sci (2013) 0.86
Antiandrogenic activity of resveratrol analogs in prostate cancer LNCaP cells. J Androl (2012) 0.84
Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation. Toxicol In Vitro (2010) 0.82
Inhibitory mechanisms of the transcriptional activity of androgen receptor by resveratrol: Implication of DNA binding and acetylation of the receptor. J Steroid Biochem Mol Biol (2010) 0.82
Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget (2016) 0.81
Molecular modelling of the androgen receptor axis: rational basis for androgen receptor intervention in androgen-independent prostate cancer. BJU Int (2005) 0.81
The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer. Recent Pat Anticancer Drug Discov (2007) 0.80
Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells. PLoS One (2014) 0.80
Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. Ann N Y Acad Sci (2015) 0.78
Down-regulation of androgen-receptor and PSA by phytochemicals. Int J Oncol (2008) 0.78
Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. Eur J Pharmacol (2008) 0.77